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Endovascular Treatment of Shunt-Induced Carotid Pseudoaneurysm:
Less Invasive but Still a Big Risk
Kuldeep Singh, MD, Danny Yakoub, MD, Jonathan Schor,MD, Jonathan
Deitch, MD, Jonathan Scheiner, MD, Christos Dossa. Staten Island Uni-
versity Hospital, Staten Island, NY
Objective: Carotid artery pseudoaneurysm (PSA) is a challenging
complication of carotid endarterectomy (CEA). We present a case and
literature review of post-CEA PSAs successfully treated percutaneously with
a covered stent.
Methods: A 57-year-old woman underwent a CEA of the left internal
carotid artery using patch closure and selective shunting using a Pruitt-Inahara
shunt. She was found to have a 3-cm incidental carotid artery PSA 3 months
later distal to the endarterectomized portion of the artery, the injury likely
resulting from the clamp or the balloon portion of the shunt. A percutaneous
5-mm 25-mmViabhan (Gore, Flagstaff, Ariz) covered stent was deployed to
successfully exclude the PSA. The patient suffered no complications. Follow-up
duplex imaging at 3 and 6 months and at 1 year confirmed PSA sealing and
patency of the internal carotid artery.
Results: A PubMed search of the topic found 15 patients (Table) with
post-CEA PSA treated with a covered stent. The results revealed the procedure
is technically feasible with acceptable patency rates, the longest being 9 years.
The procedure, however, caries a significant rate of periprocedural complica-
tions: one (7%) bleeding complication, four strokes (26%) and two deaths
(13%).
Conclusions: Endovascular repair of carotid PSA with a covered stent
can be successfully performed; however, high complication rates should be
considered before undertaking the procedure.
Review of literature on results of endovascular treatment of postoper-
ative carotid artery pseudoaneurysm using covered stents
Table.
Author/year
Age
(years) Sex
Etiology of
PSA Intervention Complications Follow-up
May, 1997 70 M Post CEA Wallgraft Embolic stoke during
deployment
US 6 months
Hertz,
2003 64 F Post CEA Wallgraft Fatal MI post-op —
Lin, 2003 74 M Post CEA Wallgraft None US 18 months
Terramani,
2003 82 M Post CEA Wallgraft Hematoma US 8 months
Baril, 2004 79 F Post CEA Viabahn None
Angiogram 12
months
McCready,
2004 58 M Post CEA Wallgraft
TIA during
deployment US 12 months
Grant, 2004 65 M Post CEA Wallgraft None US 1 year
Gupta,
2004 72 F Post CEA Viabahn None US 6 months
Jarrahnejad,
2005 79 M Post CEA Wallgraft Fatal stroke post-op —
Mousa,
2005 82 F Post CEA Wallgraft None US 6 months
Ahuja,
2007 70 M Post CEA Viabahn None US 18 months
86 F Post CEA Viabahn None US 12 months
Bigouri,
2007 76 M Post CEA Fluency Plus None US 3 months
Stein, 2007 77 F Post CEA Wallgraft None US 2 months
Troutman,
2010 66 M Post CEA Wallgraft None US 9 years
CEA, Carotid endarterectomy; PSA, pseudoaneurysm, TIA, transient
ischmic attack; US, ultrasound
Concomitant Carotid Bifurcation and Great Vessel Disease
Thomas J. Takach, MD, J. Michael Duncan, MD, James J. Livesay, MD,
David A. Ott, MD, Roberto D. Cervera, MD. Texas Heart Institute at St.
Luke’s Episcopal Hospital, Houston, Tex
Sponsored by Rabih A. Chaer, MD
Background: The management is unsettled and the prognosis ill
defined for patients with concomitant carotid bifurcation disease and great
vessel (GV) disease.
Methods: We analyzed operative outcomes, long-term patency, and
extended epidemiologic impact of the primary disease process in 80 consec-
utive patients (mean age, 63.3 years; 50.0% men) who presented with
symptomatic, concomitant carotid disease and GV disease. Each patient
underwent carotid endarterectomy (CEA; staged, n  21; simultaneous,
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